160
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study

, , , , , , , & show all
Pages 1037-1050 | Published online: 02 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lesia V Tchobaniouk, Erin E McAllister, Danielle L Bishop, Rachel M Carpentier, Katharine R Heins, Robert J Haight & Jeffrey R Bishop. (2019) Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations. Patient Preference and Adherence 13, pages 2233-2241.
Read now

Articles from other publishers (3)

Mehak Pahwa, Ahmad Sleem, Omar H. Elsayed, Megan Elizabeth Good & Rif S. El-Mallakh. (2021) New Antipsychotic Medications in the Last Decade. Current Psychiatry Reports 23:12.
Crossref
Juanita A. Haagsma, Inge Spronk, Mariska A. C. de Jongh, Gouke J. Bonsel & Suzanne Polinder. (2020) Conventional and retrospective change in health-related quality of life of trauma patients: an explorative observational follow-up study. Health and Quality of Life Outcomes 18:1.
Crossref
Ivana Clark & David Taylor. (2020) Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders. CNS Drugs 34:8, pages 841-852.
Crossref